Developing potent and scalable off-the-shelf cancer vaccines based on a proprietary allogeneic cell line of Plasmacytoid Dendritic Cells

Developing potent and scalable off-the-shelf cancer vaccines based on a proprietary allogeneic cell line of Plasmacytoid Dendritic Cells

Tuesday, October 20, 2020 7:35 AM to 8:05 AM · 30 min. (Africa/Abidjan)
Immuno-Oncology

Log in